Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
14 studies found for:    bapineuzumab

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Amyloid Imaging And Safety Study Of Subcutaneous Bapineuzumab In Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Experimental Bapineuzumab
2 Terminated
Has Results 		A Long-Term Safety And Tolerability Study Of Bapineuzumab In Alzheimer Disease Patients
Condition: Alzheimer Disease
Interventions: Drug: Bapineuzumab 0.5 mg/kg;   Drug: Bapineuzumab 1.0 m/kg
3 Terminated AAB-001 (Bapineuzumab) Open-Label, Long-Term Extension Study in Patients With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Bapineuzumab (AAB-001)
4 Terminated Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients
Condition: Alzheimer Disease
Interventions: Drug: bapineuzumab;   Drug: placebo
5 Completed Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)
Condition: Alzheimer's Disease
Interventions: Drug: Bapineuzumab 0.5 mg/kg;   Drug: Placebo Control;   Drug: Bapineuzumab 1.0 m/kg
6 Terminated Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients
Condition: Alzheimer Disease
Interventions: Drug: bapineuzumab;   Drug: placebo
7 Completed Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)
Condition: Alzheimer's Disease
Interventions: Drug: Bapineuzumab 0.5 mg/kg;   Drug: Placebo Control;   Drug: Bapineuzumab 1.0 m/kg
8 Completed
Has Results 		Study Evaluating Bapineuzumab In Alzheimer Disease Subjects
Condition: Alzheimer Disease
Interventions: Drug: bapineuzumab;   Drug: placebo
9 Terminated A Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease Patients
Condition: Alzheimer Disease
Intervention: Drug: Bapineuzumab 0.5 mg/kg
10 Terminated Study Evaluating The Long-Term Safety And Efficacy Of Subcutaneous Bapineuzumab
Condition: Alzheimer Disease
Intervention: Drug: bapineuzumab
11 Terminated A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Bapineuzumab
12 Completed
Has Results 		Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease
Condition: Alzheimer Disease
Intervention: Drug: bapineuzumab
13 Terminated Retrieval of Patient Information After Discontinuation
Condition: Alzheimer's Disease
Intervention: Drug: Bapineuzumab
14 Completed AAB-001 in Patients With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: bapineuzumab;   Other: placebo
To Top

† Indicates status has not been verified in more than two years